Liam Bendicksen is a research assistant with the Program On Regulation, Therapeutics, And Law (PORTAL) at Brigham and Women’s Hospital. His research interests include FDA law, antitrust enforcement in US health care, and the politics and implementation of drug pricing reform. His peer-reviewed work has appeared in the Food and Drug Law Journal; the New England Journal of Medicine; JAMA; the Milbank Quarterly; the Journal of Health Politics, Policy and Law; Annals of Internal Medicine; and other academic journals. He has also published articles and op-eds in STAT, Health Affairs Forefront, and the Brown Daily Herald. In his spare time, Liam writes about health policy for The Incidental Economist, a health services research blog. He graduated magna cum laude from Brown University in 2022 with concentrations in Public Policy and Public Health and plans to pursue a J.D. at Yale Law School beginning in fall 2024.
Presentation (PPTX format): What Does Chevron’s Demise Mean for FDA and Public Health?